Long-term study proves BENEO's Orafti®Synergy reduces infection duration for infants in first year of life

摘要

A RECENTLY PUBLISHED study from an EU-funded project demonstrates that the prebiotic enrichment of infant formula milk with oligofructose-enriched inulin (Orafti®Synergy) reduces the duration of infections in the first year of a baby's life.The study is part of the EARNEST project (EARly Nutrition programming-long term follow up of Efficacy and Safety Trials), an EU-funded integrated initiative. It was conducted across multiple sites and was a prospective, randomised, double-blind, placebo-controlled study. It involved 160 healthy term infants who were exclusively formula-fed and aged younger than 4 months at the outset of the study. The infant formula was either enriched with 0.8 g/100 mL of BENEO's Orafti®Synergy, a chicory root derived prebiotic, or an unsupplemented control formula. These were given until the babies were 12 months old.